The Partner State Key Laboratory of Chirosciences at the Department of Applied Biology and Chemical Technology (ABCT) of The Hong Kong Polytechnic University (PolyU) discovered a newly emerged superbug, hyper-resistant and hypervirulent Klebsiella pneumoniae, which may cause untreatable and fatal infections in relatively healthy individuals and will pose enormous threat to human health.
Prof. Chen Sheng, Professor of ABCT, collaborating with Prof. Rong Zhang from the Second Affiliated Hospital of Zhejiang University, conducted an investigation into a fatal outbreak of pneumonia in the Second Affiliated Hospital of Zhejiang University in China in February 2016. The study involved five patients who underwent surgical operation for multiple-trauma. All of them were later infected in the intensive care unit (ICU) and developed severe pneumonia, and eventually died of septicaemia and multiple organ failure. The causative agent of these five patients was found to be a carbapenem-resistant K. pneumoniae (CRKP) strain, a type of previously-defined superbug. Furthermore, these CRKP strains are also hypervirulent and belong to ST11 type of CRKP, the most prevalent and transmissible CRKP strains in Asia. As these strains simultaneously exhibit the features of hyper-resistance, hypervirulence and high transmissibility, they can be considered a real superbug known as ST11 CR-HvKP (ST11 carbapenem-resistant hypervirulent K. pneumoniae).
ST11 K. pneumoniae strains proliferate in the gastrointestinal tract (GI tract) of human and animals and may cause opportunistic infections such as pneumonia in clinical settings. These strains, after acquiring plasmid encoding a carbapenemase gene, become resistant to the carbapenem antibiotics and caused untreatable or hard-to-be treated infections, therefore defined as superbug. These superbug strains could further evolve to become ST11 CR-HvKP through acquisition of the hypervirulence plasmids. The ST11 CR-HvKP strains do not only infect lungs and cause pneumonia, but also invade the bloodstream and other internal organs. Due to its hypervirulence and phenotypic resistance to commonly used antibiotics, ST11 CR-HvKP strains may cause untreatable and fatal infections in relatively healthy individuals with normal immunity.
ST11 CR-HvKP strains possess a mucoid outer layer, which enables them to stick to various materials, such as the surface of medical devices and tubing as well as other surfaces in the ICU. The transmission route is not clear yet, but our data suggest that medical equipment such as ventilator and different catheters might be transmitting these new superbug strains. Human-to-human transmission may also be possible, mainly in hospital settings. Improved infection prevention and control policy in hospital seems to be effective to control further transmission of this superbug in the ICU. Novel strategies must be devised to prevent ST11 CR-HvKP from proliferating extensively in the human intestinal tract where they were detected. ST11 CR-HvKP can easily be detectable by the Polymerase chain reaction (PCR) method, targeting specific resistance and virulence genes. The study showed that the use of colistin (the last resort drug for carbapenem-resistant enterobacteriaceae infections) alone or in combination with other drugs were not very effective in treating infections caused by ST11 CR-HvKP. Ceftazidime/avibactam may be the effective antibiotic, but ST11 CR-HvKP may develop resistance to this antibiotic very quickly based on the clinical data from the USA.
Prevalence of ST11 CR-HvKP strains in Hong Kong is currently unknown. Two studies conducted in Hong Kong have shown that mortality rate due to K. pneumoniae-mediated bloodstream infections was high, reaching 20% and 32% respectively. We plan to collaborate with clinicians in local hospitals to investigate the proportion of clinical K. pneumoniae isolates that belong to HvKP or CR-HvKP, and characterize their genetic features.
Learn more: PolyU discovers a newly emerged superbug — hyper-resistant and hypervirulent Klebsiella pneumoniae
The Latest on: Klebsiella pneumoniae
[google_news title=”” keyword=”Klebsiella pneumoniae” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]- New antibiotic buys medicine time in the never-ending fight against superbugson May 10, 2024 at 4:15 am
Emblaveo has been developed by Pfizer, with the help of the EU and the United States, and is effective against some multidrug-resistant infections that have been untreatable until now ...
- Significant rise in cases of drug-resistant disease in east Berkshire, north east Hampshire, Farnham and Surrey Heathon May 10, 2024 at 3:04 am
The Government has vowed to tackle the spread of a drug-resistant disease branded a "significant threat" to public health.
- Fact Check: Can placing onion on feet and wearing socks cure Pneumonia?on May 8, 2024 at 5:33 am
A video on Instagram claiming that placing chopped onions on feet and covering it with socks can cure Pneumonia.Claim An Instagram video claims that onions can cure pneumonia. The video mentions ...
- Purdue pharmacy researcher receives $2.4M NIH grant to fight antimicrobial-resistant lung infectionson May 6, 2024 at 7:24 am
WEST LAFAYETTE, Ind. — Qi “Tony” Zhou, a researcher in Purdue University’s College of Pharmacy has received a $2.4 million grant from the National Institutes of Health to fight lung infections that ...
- Gut bacteria sometimes get people drunk, leading to DUIs and liver diseaseon May 5, 2024 at 3:00 am
Though it's a rare condition, a woman was acquitted of her DUI charge in 2016 after doctors diagnosed her with the same syndrome. She had a blood alcohol level four times the legal limit.
- Antimicrobial peptide from cows shows potential for treating hypervirulent bacteriaon May 2, 2024 at 6:34 am
University of Central Florida College of Medicine researcher Renee Fleeman is on a mission to kill drug-resistant bacteria, and her latest study has identified a therapy that can penetrate the slime ...
- Therapy to kill hypervirulent bacteria developedon May 1, 2024 at 5:38 pm
A study has identified a therapy that can penetrate the slime that such infections use to protect themselves from antibiotics. Scientists showed that an antimicrobial peptide from cows has potential ...
- Medical school scientist creates therapy to kill hypervirulent bacteriaon April 30, 2024 at 5:00 pm
College of Medicine researcher Renee Fleeman is on a mission to kill drug-resistant bacteria, and her latest study has identified a therapy that can penetrate the slime that such infections use to ...
- Pathogens including multi-drug resistant superbugs found on floors, ceilings and door handles of UK hospital toiletson April 29, 2024 at 3:10 pm
Pathogenic bacteria and fungi, including multi-drug resistant "superbugs" have been found on the floors, ceilings, door handles and other surfaces of hospital toilets in the UK, with patient toilets ...
- Gut microbes that get you drunk and damage your liver − how the microbiome can create a microbreweryon April 26, 2024 at 12:05 pm
People with this syndrome carry microbes in their intestines that produce abnormally high levels of alcohol when breaking down sugars and carbohydrates. Though it’s a rare condition, a woman was ...
via Google News and Bing News